Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of TelePharmaceutical Care on People With Type 2 Diabetes Melitus, Seen at the Special Medicines Pharmacy of the State of Rio Grande do Sul: a Randomized Clinical Trial (TelePharmaceutical Care Diabetes Trial)

NCT05380596 is registered in ClinicalTrials.gov with Rio Grande do Sul State Health Department - SES/RS as lead sponsor.

NCT NCT05380596
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05380596 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of TelePharmaceutical Care on People With Type 2 Diabetes Melitus, Seen at the Special Medicines Pharmacy of the State of Rio Grande do Sul: a Randomized Clinical Trial (TelePharmaceutical Care Diabetes Trial)
Lead sponsor
Rio Grande do Sul State Health Department - SES/RS
Phase
Not applicable
Overall status
Unknown status
Start date
June 1, 2022
Completion date
January 31, 2023
Enrollment
124 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabete mellitus, diabete type 2, telehealth, telemedicine